Search Results - "DeSante, K. A."

Refine Results
  1. 1

    Confidence interval criteria for assessment of dose proportionality by SMITH, Brian P, VANDENHENDE, Francois R, DESANTE, Karl A, FARID, Nagy A, WELCH, Pamela A, CALLAGHAN, John T, FORGUE, S. Thomas

    Published in Pharmaceutical research (01-10-2000)
    “…The aim of this work was a pragmatic, statistically sound and clinically relevant approach to dose-proportionality analyses that is compatible with common…”
    Get full text
    Journal Article
  2. 2

    Pharmacokinetics, Safety, and Tolerability of Atomoxetine and Effect of CYP2D610/10 Genotype in Healthy Japanese Men by Matsui, A., Azuma, J., Witcher, J. W., Long, A. J., Sauer, J.-M., Smith, B. P., DeSante, K. A., Read, H. A., Takahashi, M., Nakano, M.

    Published in Journal of clinical pharmacology (01-03-2012)
    “…Atomoxetine is a cytochrome P4502D6 (CYP2D6) substrate. The reduced-activity CYP2D6*10 allele is particularly prevalent in the Japanese population and may…”
    Get full text
    Journal Article
  3. 3

    Sensitive and specific radioimmunoassay for fialuridine: initial assessment of pharmacokinetics after single oral doses to healthy volunteers by BOWSHER, R. R, COMPTON, J. A, KIRKWOOD, J. A, PLACE, G. D, JONES, C. D, MABRY, T. E, HYSLOP, D. L, HATCHER, B. L, DESANTE, K. A

    Published in Antimicrobial Agents and Chemotherapy (01-09-1994)
    “…Classifications Services AAC Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit…”
    Get full text
    Journal Article
  4. 4

    Pharmacokinetics of dirithromycin by Sides, G D, Cerimele, B J, Black, H R, Busch, U, DeSante, K A

    Published in Journal of antimicrobial chemotherapy (01-03-1993)
    “…Dirithromycin is a new member of the macrolide class of antibiotics and has been developed for oral administration. Dirithromycin is a 14-membered lactone ring…”
    Get more information
    Journal Article
  5. 5

    Why rate of absorption inferences in single dose bioequivalence studies are often inappropriate by BASSON, R. P, GHOSH, A, CERIMELE, B. J, DESANTE, K. A, HOWEY, D. C

    Published in Pharmaceutical research (01-02-1998)
    “…Peak drug concentration (Cmax) measures the extremity of drug exposure and is a secondary indicator of the extent of absorption after area under the…”
    Get full text
    Journal Article
  6. 6

    Tmax : an unconfounded metric for rate of absorption in single dose bioequivalence studies by BASSON, R. P, CERIMELE, B. J, DESANTE, K. A, HOWEY, D. C

    Published in Pharmaceutical research (01-02-1996)
    “…While peak drug concentration (Cmax) is recognized to be contaminated by the extent of absorption, it has long served as the indicator of change in absorption…”
    Get full text
    Journal Article
  7. 7

    Disposition of zatosetron, a serotonin (5-HT3) receptor antagonist, in humans by Franz, P M, Mattiuz, E L, Hatcher, B L, DeSante, K A, Breau, A P, Occolowitz, J L, Dorman, D E, Schmid, C R, Goldberg, M J, Rubin, A

    Published in Drug metabolism and disposition (01-03-1993)
    “…Zatosetron is being tested clinically as an antianxiety agent; it is a highly selective antagonist of the serotonin 5-HT3 receptor, with minimal agonist…”
    Get more information
    Journal Article
  8. 8

    Effects of renal dysfunction on the pharmacokinetics of loracarbef by Therasse, D G, Farlow, D S, Davidson, R L, Quadracci, L J, Hatcher, B L, Cerimele, B J, DeSante, K A

    Published in Clinical pharmacology and therapeutics (01-09-1993)
    “…Loracarbef, the first carbacephem antibiotic to undergo clinical development, is excreted primarily unchanged in the urine (> 90%). Data analyzed from subjects…”
    Get more information
    Journal Article
  9. 9
  10. 10

    Clinical pharmacokinetics of pinacidil, a potassium channel opener, in hypertension by Goldberg, M R, Rockhold, F W, Thompson, W L, DeSante, K A

    Published in Journal of clinical pharmacology (01-01-1989)
    “…Pinacidil is a potassium channel opener that decreases blood pressure by reducing peripheral arterial resistance. In two multicenter trials, we studied the…”
    Get more information
    Journal Article
  11. 11

    Disposition of [14C]pinacidil in humans by DeLong, A F, Oldham, S W, DeSante, K A, Nell, G, Henry, D P

    Published in Journal of pharmaceutical sciences (01-02-1988)
    “…Pinacidil [(+/-)-2-cyano-1-(4-pyridyl)-3-(1,2,2-trimethylpropyl)guanidine monohydrate] is a novel, direct-acting vasodilator antihypertensive agent. The cyano…”
    Get more information
    Journal Article
  12. 12

    Disposition in humans of racemic picenadol, an opioid analgesic by Franz, P M, Anliker, S L, Callaghan, J T, DeSante, K A, Dhahir, P H, Nelson, R L, Rubin, A

    Published in Drug metabolism and disposition (01-11-1990)
    “…Racemic picenadol is being tested clinically as an analgesic. The (+)-enantiomer of picenadol is an opioid agonist and the (-)-enantiomer is a weak…”
    Get more information
    Journal Article
  13. 13

    Sensitive, specific radioimmunoassay for quantifying pergolide in plasma by Bowsher, R R, Apathy, J M, Compton, J A, Wolen, R L, Carlson, K H, DeSante, K A

    Published in Clinical chemistry (Baltimore, Md.) (01-10-1992)
    “…Pergolide, a synthetic ergoline with potent dopaminergic activity, is used to treat Parkinson disease. The low plasma concentrations of pergolide achieved…”
    Get more information
    Journal Article
  14. 14

    Pharmacokinetics of cefaclor AF: effects of age, antacids and H2-receptor antagonists by Satterwhite, J H, Cerimele, B J, Coleman, D L, Hatcher, B L, Kisicki, J, DeSante, K A

    Published in Postgraduate medical journal (1992)
    “…The pharmacokinetics and bioavailability of cefaclor advanced formulation (cefaclor AF) were investigated in two studies, one comparing healthy elderly and…”
    Get full text
    Journal Article
  15. 15
  16. 16

    Effect of probenecid on the pharmacokinetics of moxalactam by DeSante, K A, Israel, K S, Brier, G L, Wolny, J D, Hatcher, B L

    Published in Antimicrobial Agents and Chemotherapy (01-01-1982)
    “…Classifications Services AAC Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit…”
    Get full text
    Journal Article
  17. 17

    Single- and multiple-dose pharmacokinetics of moxalactam in normal subjects by Israel, K S, Black, H R, Brier, G L, Wolny, J D, DeSante, K A

    Published in Antimicrobial Agents and Chemotherapy (01-07-1982)
    “…Classifications Services AAC Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit…”
    Get full text
    Journal Article
  18. 18

    Bioavailability and pharmacokinetics of prednisone in humans by Disanto, A R, Desante, K A

    Published in Journal of pharmaceutical sciences (01-01-1975)
    “…In a clinical study involving 22 normal adult volunteers, the bioavailability and pharmacokinetics of prednisone tablets with varying dissolution rates were…”
    Get more information
    Journal Article
  19. 19

    Lincomycin serum and saliva concentrations after intramuscular injection of high doses by Smith, R B, Lummis, W L, Monovich, R E, DeSante, K A

    Published in Journal of clinical pharmacology (01-10-1981)
    “…Serum and saliva levels of lincomycin were determined in 15 normal adult male volunteers after a single intramuscular injection of 600, 1000, or 1500 mg…”
    Get more information
    Journal Article
  20. 20

    Pharmacokinetic profile of loracarbef by DeSante, K A, Zeckel, M L

    Published in The American journal of medicine (22-06-1992)
    “…Loracarbef, the first beta-lactam antibiotic of the carbacephem class to undergo clinical evaluation, has been the subject of extensive clinical pharmacology…”
    Get more information
    Journal Article